LDL in mesangial cells Biphasic regulation of plasminogen activator/inhibitor by

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• mRNA expression of urokinase and plasminogen activator inhibitor‐1 in human crescentic glomerulonephritis

  2001cited by this paper
• Induction of metalloproteinases by glomerular mesangial cells stimulated by proteins of the extracellular matrix.

  2001cited by this paper
• Advanced glycosylation end products stimulate collagen mRNA synthesis in mesangial cells mediated by protein kinase C and transforming growth factor-beta.

  2001cited by this paper
• Plasminogen activator inhibitor type 1 is a potential target in renal fibrogenesis.

  2000cited by this paper
• LDL stimulates collagen mRNA synthesis in mesangial cells through induction of PKC and TGF-β expression.

  1999cited by this paper
• Oxidized LDL and lysophosphatidylcholine stimulate plasminogen activator inhibitor-1 expression in vascular smooth muscle cells.

  1999cited by this paper
• Fibrin zymography: a direct analysis of fibrinolytic enzymes on gels.

  1998cited by this paper
• Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration.

  1997cited by this paper
• Plasminogen and Plasminogen Activators Protect against Renal Injury in Crescentic Glomerulonephritis

  1997cited by this paper
• Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix.

  1996cited by this paper
• Involvement of oxidation in LDL-induced collagen gene regulation in mesangial cells.

  1996cited by this paper
• ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade.

  1995cited by this paper
• Protein kinase C and lipid signaling for sustained cellular responses

  1995cited by this paper
• Heparin selectively inhibits synthesis of tissue type plasminogen activator and matrix deposition of plasminogen activator inhibitor 1 by human mesangial cells.

  1994cited by this paper
• Lipids and the kidney.

  1994cited by this paper
• Visualization of binding and uptake of oxidized low density lipoproteins by cultured mesangial cells.

  1994cited by this paper
• Two-chain urokinase, receptor, and type 1 inhibitor in cultured human mesangial cells.

  1993cited by this paper
• Oxidized low density lipoproteins stimulate phosphoinositide turnover in cultured vascular smooth muscle cells.

  1992cited by this paper
• Physiological mechanisms for metalloproteinase activation.

  1992cited by this paper
• Role of plasmin and gelatinase in extracellular matrix degradation by cultured rat mesangial cells.

  1992cited by this paper
• Cell-specific regulation of plasminogen activator inhibitor 1 and tissue type plasminogen activator release by human kidney mesangial cells.

  1992cited by this paper
• Lipids and progressive kidney disease.

  1991cited by this paper
• The majority of type 1 plasminogen activator inhibitor associated with cultured human endothelial cells is located under the cells and is accessible to solution-phase tissue-type plasminogen activator

  1990cited by this paper
• Characterization of a plasminogen activator and its inhibitor in human mesangial cells.

  1989cited by this paper
• Amiloride selectively inhibits the urokinase‐type plasminogen activator

  1987cited by this paper
• Plasminogen activator inhibitors.

  1987cited by this paper
• Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor.

  1986cited by this paper
• The human tissue plasminogen activator gene.

  1986cited by this paper
• Identification and primary sequence of an unspliced human urokinase poly(A)+ RNA.

  1984cited by this paper

• No citing papers are available for this paper.